THE ROLE of humoral antibody in the rejection of neoplastic tissue has been at issue for many years. The results of early experiments (see reviews by Gorer, 1961 and M6ller, 1963) established that tumour cells were susceptible to the cytolytic action of antibodies and complement in vitro and that passively administered cytotoxic antisera would eliminate homografts of leukaemia cells, though not usually solid tumour grafts, in vivo. In most of these experiments, however, demonstrably cytotoxic antisera could be raised only by immunizing strains of animals with different major histocompatibility (MHC) antigens from those of the donor of the tumour graft; antisera to non-MHC histocompatibility antigens were not usually cytotoxic in vitro, and the passive transfer of such antisera frequently enhanced the growth of leukaemia and solid-tumour grafts (Moller, 1963) rather than their rejection.
In our studies on the immune responses between the MHC-compatible August and Lister Hooded rat strains, we have found that antisera raised in August rats against the minorhisto-incompatibilities of Hooded rats may have weak or non-existent complement-mediated cytotoxicity to Hooded rat leukaemia (HRL) cells in vitro, and yet effect rapid rejection of the grafted leukaemia cells on passive transfer of the serum in vivo. In this paper we demonstrate that August anti-Hooded serum mediates the rapid removal of grafted leukaemia cells from the circulation by their destruction in the spleen and liver. Antibody has been implicated in the control of haematogenous spread of syngeneic and autochthonous tumours (Alexander & Hall, 1970) and we suggest that the manner in which antibody mediates the elimination of HRL in August rats may represent the principal mechanism by which the host can remove cells bearing weak histo-incompatibilities from the circulation.
MATERIALS ANI) METHOI)S
Rats.-Pure-line Lister Hooded Cbi and August (both AgB5 or Rtl C) rats were bred at our own laboratories, and used when aged between 10 weeks and 6 months; their weight range was 150-250 g. Compatibility of the August and Hooded strains at the MHC was confirmed by the use of our own antisera raised in other rat strains, and by commercially available anti-AgB5 alloantiserum (Searle Diagnostic, High Wycombe). We were unable to induce mixed lymphocyte responses (MLR) in cultures containing mixtures of August and Hooded rat lymphocytes, a result which is consistent with the report of Cramer et al. (1974) that the August and Hooded rat strains have identical MLR phenotypes.
The Hooded rat leukaemia (HRL). HRL is a spontaneously arising acute T-cell leukaemia which is extremely pathogenic in the syngeneic male host (Wrathmell, 1976) Heat-killing of cells. HRL cells were incubated at 56°C for 30 min.
X-irradiation of rats. 4-5 Gy w%hole-body irradiation was delivered by a Marconi X-ray machine at 220 kV with no filtration at a dose rate of 0-8 Gy/min.
Purification of cobra venom factor (CVF).-CVF was purified from Naja naja venom (Sigma Chemical Co. Ltd) by the methods described by Lachmann et al. (1976) . Phospholipase A was inactivated with p-bromophenacyl bromide. Sixty-five ,ul of the purified factor per rat was sufficient to decomplement the rats for 24 h. Decomplementation w%vas assessed by the inability of the recipients' serum to induce lysis of sheep red blood cells (SRBC) presensitized with rat anti-sheep serum.
Affinity fractionation of A UG anti-HO serum. Three fractions were prepared from the whole antiserum: total immunoglobulin, "IgM-rich" and IgG only. Specifically purified rabbit anti-rat F(ab')2 or sheep anti-rat IgM wvere covalently linked to activated CNBr Sepharose 4BR (Pharmacia, Gt Britain Ltd) and 4 ml AUG anti-HO serum was then adsorbed on to either conjugate. The unbound materials were eluted with lM NaCl in phosphate buffer and specifically adsorbed material was eluted with 3M KSCN and dialysed against PBS. An IgG preparation from AUG anti-HO serum was obtained by applying the 5000 (NH4)2SO4 precipitable material to DEAE cellulose. The precipitate was dissolved in 17-5 mm phosphate buffer and eluted from the DEAE in the same buffer. The IgGcontaining fractions were then adsorbed on to Sepharose-linked anti-rat F(ab')2 and the unbound material discarded. The fractions were concentrated to the original antiserum volume by ultrafiltration (PM1O diaflo ultra filter, Amicon, Massachusetts). Individual immunoglobulins in the fractions were measured by the ability of the flactions to inhibit the agglutination of glutaraldehyde-fixed SRBC coated with purified rat immunoglobulin-s in the presence of anti-rat-immunoglobulin antibodies. The IgG preparation from AUG anti-HO serum had virtually no IgM, IgA or IgE activities, as determined by passive haemagglutination inhibition.
RESULTS

Protection of X-irradiated August rats against the growth of HRL cells by AUG anti-HO serumn
Normal August rats rejected large numbers of HRL cells at the first immunization. If August rats were given totalbody irradiation with 4-5 Gy X-rays, however, an inoculum of as few as 104 HRL cells would grow to kill the recipients within 3 weeks. X-irradiated August rats could be protected against a potentially lethal dose of HRL by pretreatment with AUG anti-HO serum. Table I shows the results of 3 experiments in which Xirradiated August rats were protected against death from leukaemia with antiserum. 1251 activity in the cell-free plasma of rats treated with antiserum rose to a maximum of 70% of the total blood activity at 3 and 6 h; in the control rats, less than 20% of the blood activity was in the cell-free plasma at 5 min and 3 h but this increased to ' 50 % after 3 h.
The volumes of antiserum required per rat to demonstrate accelerated elimination of 1251-HRL in liver and spleen were far smaller than those needed to protect Xirradiated August rats against death from leukaemia; differential loss of 1 251 was detectable at 0 1-0-2 ml AUG anti-HO serum per rat, whereas 2-5-3-0 ml of antiserum was the minimum volume needed to ensure the survival of Xirradiated rats given HRL cells (data in Table I heat-killed I 251-labelled HRL cells were given to August rats in the presence or absence of antiserum. Fig. 2 shows 1251 activities recovered from lung, spleen and liver at times after the injection of killed labelled cells. Immediately after injection (i.e. at 5 min) most of the injected 1251 activity was recovered from the lungs of rats treated with antiserum or normal August serum, but by 1 h the mean activity recovered from the lungs had fallen to l1* and 1*2500 respectively, without compensatory increases in 1 251 activity in liver and spleen. 1 251 activities recovered from the thyroid and blood plasma of both groups of rats at 1 h were negligible, indicating that the bulk of 125J from killed HRL cells had been excreted within the first hour after their injection. As Fig. 2 shows, the uptake and loss of 1251 in liver and spleen following injection of dead HRL cells were identical in rats treated with AUG anti-HO serum and in those given normal serum.
Characterization of the effective antibody
The immunoglobulin fractions prepared from whole AUG anti-HO serum were tested for their ability to increase the rate of disappearance of 1251-HRL in August rats as compared with the effects of normal serum. 1 251 activities in the livers and spleens were counted 20 h after the injection of 1251-HRL cells into rats pretreated with the fractions under test or control sera. The amount of fractionated immunoglobulin given per rat was made roughly equivalent to the amount fouind in 0 5 ml of the whole antiserum. Table III 
Inmntnophagocytosis in the antibodymediated rejection of HRL cells
The results of 51Cr release from labelled HRlL cells in vitro indicated that most of the AUG anti-HO sera used by us had negligible C'-dependent lytic activity. The highest lytic titres (e.g. 500o specific lysis at 1/5 dilution of the antiserum with rabbit serum as C' source) were obtained with antisera raised against HRL cells; no specific lysis was detectable with antisera raised against Hooded rat skin or sarcoma. Demonstration that the haemolytic components of complement were not required for the in vivo destruction of 125I-HRL Table IV . In August rats that were given active CVF, decomplementation was complete 0 5 h after the receipt of CVF, and remained complete until the animals were killed for 125J counting at 20 h. The rate of elimination of 12514HRL cells in the presence of AUG anti-HO antibody was unaffected by total-body Xirradiation of the recipient rats with 4 5 Gy, which corroborated the results of the passive protection experiments (Table I) .
Since the X-irradiation could be performed from 4 days to 4 h before injection of 1251-HRI, and yet have no effect, it seemed likely that macrophages resident in spleen and liver, rather than cells freshly recruited from the circulation, were the agents whereby antibody-coatedleukaemia cells were destroyed. To test this hypothesis, therefore, groups of rats were treated with colloidal carbon in an attempt to blockade the reticulo-endothelial system before injection of 1251-HRL cells. injected with 1251-HRL cells. Carbon retarded the rate of disappearance of 1251 from the livers of antiserum-treated rats, and its effects appeared to be most marked during the first 2-3 h after its injection; thereafter the rates at which 1 251 activity disappeared from the livers of antiserum-treated rats were similar in carbon-treated and untreated rats. The non-immunological removal of 1251-HRL cells (as represented by 1 251 activities in the livers of animals treated with normal serum) appeared to be only slightly retarded by carbon, which probably reflects the far slower rate of removal of moribund cells by macrophages than the rate of phagocytosis of cells opsonized with antibody. The effect of carbon on the antibodymediated clearance of 125I-HRL cells in the spleen was less apparent than its effect on liver clearance. Slight retardation of the loss of 125J in the spleen was detectable 2 h after the injection of 1251-HRL cells, but at 3 h residual activities in the spleens of carbon-treated animals were similar to those in the spleens of rats treated with antiserum alone. The failure of carbon to produce a more marked effect on the rate of splenic clearance of HRL cells may be the result of a faster rate of elimination of carbon by the spleen than by liver. (Anderson & Warner, 1976) and our results suggest that it is these cells which clear opsonized leukaemia cells from the circulation by immunophagocytosis. Shin et at. (1974) have also reported that alloantibody can suppress lymphoma growth in mice by co-operation with host cells. In these authors' experiments, however, antibody could not mediate tumour suppression in sublethally X-irradiated mice, but the response could be restored by a variety of cell types from unirradiated mice: macrophages, lymphocytes, polymorphonuclear leucocytes and platelets all restored the capacity of the host to suppress lymphoma growth in the presence of antibody. To add to a confused picture, frozen-and-thawed macrophages also mediated the suppression of lymphoma growth, and the authors concluded that the mechanism did not involve immunophagocytosis. It is possible that the pattern of effector mechanisms generated between the rat strains used by us differs from that between the mouse strains used by Shin and his co-workers.
The MHC-compatible August and Hooded rat strains differ at the Pta locus (Howard & Scott, 1974) (Butcher & Howard, 1977) that anti-Pta antibodies are not raised by skin grafting. The tissue distribution of the antigens to which the various August anti-Ho sera are directed has been investigated by an anti-globulin binding assay; the results from this will be discussed in a further publication (Hooton et al., in preparation) . In their studies on the antibody responses to histocompatibility antigens in rats, Miller & De Witt (1974) found that IgM antibodies were not formed to minor histocompatibilities and that these antigens preferentially evoked the production of non-complement-fixing
IgG. In our experiments we also have found that the effective antibody against a graft bearing non-MHC histocompatibility differences is IgG, not IgM, and that its action in vivo is independent of complement-mediated lysis.
The results of past studies have shown that, in general, antisera which are not cytolytic to tumour cells in vitro are not able to confer protection against the same cells in vivo, and it has been a common experience that antisera directed against histocompatibility antigens which are not part of the MHC do not usually have antitumour activity either in vivo or in vitro (M6ller, 1963) . Our August anti-HO sera were not strongly cytolytic in vitro but were extremely effective against HRL cells in vivo. The effective action of antibody against HRL cells may have been related to the physical nature of the graft and the manner in which it was introduced to the host in our experiments. One might predict that an i.v. single-cell suspension would be more accessible to the action of antibody than a peripheral graft of solid tissue, and we are currently investigating the effects of August HO sera on the growth of Hooded rat sarcomas. The elimination of circulating tumour cells in the liver and spleen via the action of antibody is particularly relevant to the mechanism by which the vascular spread of syngeneic or autochthonous tumours may be controlled by the immune response. Citations of positive anti-tumour activity in vivo by antibodies to tumour-associated antigens are few, but in one study from our laboratory (Proctor et al., 1973) an immunologically specific factor in the lymph and blood of rats with syngeneic sarcomas was found to prevent the development of lung metastases. Although the factor was not positively identified as antibody, it was shown to be humoral in nature and unassociated with sensitized mononuclear cells.
